Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Graziani

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 7, 2020
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020Filippo Lagi, Matteo Piccica, Lucia Graziani, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2022
Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19Lucia Graziani, Leonardo Gori, Tommaso Manciulli, et al.
Journal of Clinical Immunology|July 2, 2022
Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological ImplicationsMichele Spinicci, Alessio Mazzoni, Marco Coppi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 26, 2021
Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in ItalyFilippo Lagi, Sasha Trevisan, Matteo Piccica, et al.
Viruses|November 11, 2022
Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID PhenotypesMichele Spinicci, Lucia Graziani, Marta Tilli, et al.
Journal of Clinical Immunology|July 9, 2022
Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring HospitalizationGiulia Lamacchia, Alessio Mazzoni, Michele Spinicci, et al.
The Journal of Antimicrobial Chemotherapy|August 22, 2023
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscapeDaniele Roberto Giacobbe, Cristina Marelli, Greta Cattardico, et al.
BMC Infectious Diseases|October 16, 2025
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort studyAndrea Lombardi, Daniele Roberto Giacobbe, Davide Mangioni, et al.
Infectious Diseases and Therapy|July 12, 2024
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort StudyDaniele Roberto Giacobbe, Laura Labate, Chiara Russo Artimagnella, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 7, 2020
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020Filippo Lagi, Matteo Piccica, Lucia Graziani, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2022
Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19Lucia Graziani, Leonardo Gori, Tommaso Manciulli, et al.
Journal of Clinical Immunology|July 2, 2022
Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological ImplicationsMichele Spinicci, Alessio Mazzoni, Marco Coppi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 26, 2021
Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in ItalyFilippo Lagi, Sasha Trevisan, Matteo Piccica, et al.
Viruses|November 11, 2022
Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID PhenotypesMichele Spinicci, Lucia Graziani, Marta Tilli, et al.
Journal of Clinical Immunology|July 9, 2022
Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring HospitalizationGiulia Lamacchia, Alessio Mazzoni, Michele Spinicci, et al.
The Journal of Antimicrobial Chemotherapy|August 22, 2023
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscapeDaniele Roberto Giacobbe, Cristina Marelli, Greta Cattardico, et al.
BMC Infectious Diseases|October 16, 2025
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort studyAndrea Lombardi, Daniele Roberto Giacobbe, Davide Mangioni, et al.
Infectious Diseases and Therapy|July 12, 2024
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort StudyDaniele Roberto Giacobbe, Laura Labate, Chiara Russo Artimagnella, et al.
Pageof 2